Decoy Therapeutics Inc. (DCOY)
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Decoy Therapeutics Inc.
NASDAQ:DCOYHealthcare · Biotechnology
-13.01%$1.07
AH$1.08+0.93%vs close
Mkt Cap$2.55M
Float2.25M
O/S2.39M
Vol
$ Vol
RVOL
Inst Own0.2%
SI4.3%
Earnings
Dilution
MCap$2.55M
Float2.25M
O/S2.39M
Dilution
Financials Summary
Revenue$0
Net Income-$12.52M
Total Assets$11.06M
Free Cash Flow-$4.83M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$5.89M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:12
Nasdaq bars a compliance period at 1:250
- 1:12Reverse splitMar 9, 202612 shares → 1
Balance Sheet Details
Assets$11.06M
Liabilities$5.17M
Accounts Receivable$0
Accounts Payable$941K
Inventory$0
PP&E (Net)$41K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $5.23M | $3.47M | $838K | $1.27M | $1.01M | $0 | $0 |
| YoY Growth | - | - | - | - | - | 51.0% | 313.4% | -34.2% | 26.1% | - | - | - |
| Cost of Revenue | $8.52M | $0 | $0 | $0 | $0 | $0 | $0 | $431K | $507K | $663K | $50K | $12K |
| Gross Profit | -$8.52M | $0 | $0 | $0 | $0 | $5.23M | $3.47M | $407K | $768K | $348K | -$50K | -$12K |
| Gross Margin | - | - | - | - | - | 100.0% | 100.0% | 48.6% | 60.3% | 34.4% | - | - |
| Research and Development | $368K | $770K | $7.17M | $15.84M | $8.55M | $6.91M | $4.02M | $11.91M | $16.99M | $20.38M | $12.75M | $4M |
| Selling, General, and Administrative | $3.73M | $4.96M | $5.72M | $7.14M | $6.1M | $6.11M | $7.71M | $10.57M | $18.5M | $19.86M | $16.46M | $4.01M |
| Other | $0 | $0 | $0 | $8.87M | -$1.84M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $4.1M | $5.73M | $12.89M | $31.84M | $12.81M | $13.02M | $11.73M | $22.48M | $35.49M | $40.23M | $29.21M | $8.02M |
| Operating Income (EBIT) | -$12.61M | -$5.73M | -$12.89M | -$31.84M | -$12.81M | -$7.79M | -$8.27M | -$22.07M | -$34.73M | -$39.89M | -$29.21M | -$8.03M |
| Operating Margin | - | - | - | - | - | -148.8% | -238.5% | -2633.7% | -2724.6% | -3946.5% | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $3K | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $95K | $159K | $352K | $219 | $0 | $0 | $16K | $152K | $292K | $393K | $0 | $19K |
| Other Income (Expense) | $95K | $159K | $352K | $233K | $45K | $434K | $1.33M | $152K | $292K | $393K | $72K | $19K |
| Income Before Tax (EBT) | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$21.92M | -$34.43M | -$39.49M | -$29.14M | -$8.01M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $630 | $0 |
| Net Income | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$21.92M | -$34.43M | -$39.49M | -$29.14M | -$8.01M |
| Net Income Margin | - | - | - | - | - | -140.5% | -200.2% | -2615.6% | -2701.7% | -3907.6% | - | - |
| Supplementary Data | ||||||||||||
| EPS | -25.99 | -86.92 | -461.04 | -1785.33 | -926.01 | -1415.85 | -6366.21 | -87374.00 | -149250.00 | -182250.00 | -156000.00 | -342750.00 |
| Diluted EPS | -25.99 | -86.92 | -461.04 | -1785.33 | -926.01 | -1415.85 | -6366.21 | -87374.00 | -149250.00 | -182250.00 | -156000.00 | -342750.00 |
| Weighted Average OS | 481,587 | 64,147 | 27,205 | 17,704 | 13,788 | 5,192 | 1,089 | 21 | 230 | 216 | 187 | 23 |
| EBITDA | -$12.51M | -$5.57M | -$12.53M | -$22.97M | -$12.75M | -$7.59M | -$8.14M | -$21.85M | -$34.4M | -$39.61M | -$29.09M | -$8M |
| EBITDA Margin | - | - | - | - | - | -145.1% | -234.8% | -2606.5% | -2699.2% | -3919.1% | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $10.71M | $2.43M | $5.9M | $12.11M | $29.21M | $11.12M | $3.74M | $9.83M | $19.19M | $22.42M | $66.69M | $33.85M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.13M | $38.66M | $24.65M | $0 |
| Cash and Short-Term Investments | $10.71M | $2.43M | $5.9M | $12.11M | $29.21M | $11.12M | $3.74M | $9.83M | $33.32M | $61.07M | $91.34M | $33.85M |
| Accounts Receivable | $0 | $0 | $0 | $1.61M | $0 | $3.86M | $0 | $10K | $10K | $12K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $187K | $432K | $454K | $0 | $0 |
| Other Current Assets | $275K | $222K | $151K | $168K | $173K | $138K | $0 | $249K | $768K | $0 | $0 | $0 |
| Total Current Assets | $10.99M | $2.99M | $6.52M | $14.52M | $30.16M | $15.8M | $4.69M | $10.32M | $34.54M | $62.47M | $92.25M | $34.22M |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $41K | $0 | $0 | $0 | $8K | $23K | $25K | $74K | $331K | $556K | $382K | $85K |
| Goodwill | $0 | $0 | $0 | $0 | $8.87M | $8.87M | $8.87M | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $66K | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $1.61M | $0 | $0 | $0 | $0 | $0 | $2.31M | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $50K |
| Other Long-Term Assets | $31K | $35K | $67K | $131K | $186K | $247K | $309K | $460 | $60K | $191K | $127K | $1.25M |
| Total Long-Term Assets | $72K | $35K | $67K | $131K | $10.67M | $9.14M | $9.2M | $74K | $458K | $748K | $2.82M | $1.39M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $11.06M | $3.02M | $6.59M | $14.65M | $40.83M | $24.93M | $13.89M | $10.39M | $34.99M | $63.21M | $95.07M | $35.61M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $941K | $937K | $603K | $2.86M | $1.54M | $1.85M | $1.79M | $343K | $2M | $1.19M | $876K | $579K |
| Short-Term Debt | $0 | $222K | $290K | $0 | $0 | $477K | $502K | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $3.23M | $0 | $0 | $0 | $0 | $0 | $542K | $0 | $72K | $88K | $0 | $0 |
| Other Current Liabilities | $2K | $0 | $0 | $0 | $0 | $59K | $318K | $3.91M | $2.9M | $1.16M | $673K | $290K |
| Total Current Liabilities | $5.17M | $1.51M | $1.3M | $4.27M | $2.11M | $2.77M | $3.31M | $5.02M | $5.85M | $3.89M | $2.85M | $1.07M |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $50K |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $39K | $8K | $30K | $41.03M |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $39K | $8K | $30K | $41.08M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$738 |
| Total Liabilities | $5.17M | $1.51M | $1.3M | $4.27M | $2.11M | $2.77M | $3.31M | $1.11M | $5.89M | $3.9M | $2.88M | $42.15M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $53 | $144 | $393 | $225 | $5K | $2K | $451 | $2K | $2K | $2K | $2K | $221 |
| Retained Earnings | -$94.44M | -$81.92M | -$76.35M | -$63.81M | -$32.2M | -$19.43M | -$12.08M | -$132.96M | -$111.08M | -$76.65M | -$37.15M | -$8.01M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1K | -$2K | -$25K | -$15.64M |
| Other Stockholders' Equity | $100.33M | $83.44M | $81.63M | $74.19M | $70.92M | $41.59M | $22.66M | $142.24M | $140.18M | $135.96M | $129.34M | $1.47M |
| Total Equity | $5.89M | $1.51M | $5.29M | $10.38M | $38.72M | $22.16M | $10.58M | $9.28M | $29.11M | $59.32M | $92.19M | -$6.54M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $11.06M | $3.02M | $6.59M | $14.65M | $40.83M | $24.93M | $13.89M | $10.39M | $34.99M | $63.21M | $95.07M | $35.61M |
| Supplementary Data | ||||||||||||
| Total Debt | $0 | $222K | $290K | $0 | $0 | $477K | $502K | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$10.71M | -$2.21M | -$5.61M | -$12.11M | -$29.21M | -$10.64M | -$3.24M | -$9.83M | -$19.19M | -$22.42M | -$66.69M | -$33.85M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$21.92M | -$34.43M | -$39.49M | -$29.14M | -$8.01M |
| Depreciation & Amortization | $7K | $4K | $10K | $7K | $19K | $18K | $127K | $228K | $325K | $277K | $50K | $12K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10K | $0 |
| Stock-Based Compensation | $219K | $274K | $525K | $797K | $559K | $319K | $752K | $1.94M | $4.22M | $6.57M | $6.6M | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | $0 | $0 | $1.48M | $0 | $2.25M | -$3.86M | $690 | $7K | $2K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $1K | $228K | $22K | $0 | $0 | $0 |
| Accounts Payable | -$1.17M | $334K | -$2.26M | $1.31M | -$311K | -$3K | -$519K | -$1.66M | $819K | $309K | $621K | $0 |
| Other Working Capital | $121K | $438K | -$193K | $1.06M | $100K | $821K | -$3.69M | -$2.45M | $1.39M | $262K | $1.11M | $128K |
| Total Working Capital Change | -$1.05M | $772K | -$968K | $2.37M | $2.03M | -$3.04M | -$4.21M | -$3.88M | $2.23M | $571K | $1.73M | $128K |
| Other Non-Cash Items | $8.51M | $0 | $130K | $10.84M | -$45K | -$259K | -$1.31M | $32K | -$66K | $20K | $4K | $942K |
| Net Cash from Operating | -$4.83M | -$4.53M | -$12.85M | -$17.6M | -$10.2M | -$10.31M | -$11.58M | -$23.6M | -$27.72M | -$32.05M | -$20.75M | -$6.93M |
| Investing Activities | ||||||||||||
| Capital Expenditures | $0 | $0 | -$3 | $0 | $0 | -$3K | $0 | $0 | -$113K | -$559K | -$266K | -$76K |
| Acquisitions | $1.34M | $0 | $0 | $0 | $0 | $0 | $5.61M | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2M | -$32.99M | -$38.68M | -$39.4M | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $16.12M | $57.59M | $27M | $12.4M | $0 |
| Other Investing Activities | -$577K | $0 | $3 | -$1.5M | $0 | $0 | $0 | $5K | $5K | $5K | $0 | $0 |
| Net Cash from Investing | $765K | $0 | $0 | -$1.5M | $0 | -$3K | $5.61M | $14.12M | $24.49M | -$12.24M | -$27.27M | -$76K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | - | - | - | $477K | $974K | $418K | - | - | - | - | - |
| Common Stock Issuance | $12.56M | $1.53M | $6.92M | $1.99M | $27.29M | $14.8M | $4.13M | $118K | $3K | $22K | $80.44M | $40.99M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | -$134K | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $1.49M | $3.87M | $0 | $118K | $0 | $0 | $400K | $0 |
| Net Cash from Financing | $12.34M | $1.06M | $6.64M | $1.99M | $28.3M | $17.69M | $3.58M | $118K | $3K | $22K | $80.84M | $40.99M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$127K |
| Net Change in Cash | $8.28M | -$3.47M | -$6.21M | -$17.11M | $18.1M | $7.38M | -$2.39M | -$9.36M | -$3.23M | -$44.27M | $32.83M | $33.85M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$4.83M | -$4.53M | -$12.85M | -$17.6M | -$10.2M | -$10.31M | -$11.58M | -$23.6M | -$27.72M | -$32.05M | -$20.75M | -$6.93M |
| Capital Expenditure | $0 | $0 | -$3 | -$1.5M | $0 | -$3K | $0 | $0 | -$113K | -$559K | -$266K | -$76K |
| Free Cash Flow | -$4.83M | -$4.53M | -$12.85M | -$19.1M | -$10.2M | -$10.31M | -$11.58M | -$23.6M | -$27.84M | -$32.61M | -$21.01M | -$7.01M |
| Cash at Beginning | $2.43M | $5.9M | $12.11M | $29.21M | $11.12M | $3.74M | $6.13M | $19.31M | $22.42M | $66.69M | $33.85M | $0 |
| Cash at End | $10.71M | $2.43M | $5.9M | $12.11M | $29.21M | $11.12M | $3.74M | $9.96M | $19.19M | $22.42M | $66.69M | $33.85M |